These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1812297)

  • 1. Pharmacological profile of the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146) in the cardiovascular system.
    Kogi K; Uchibori T; Aihara K; Yamaguchi T; Abiru T
    Jpn J Pharmacol; 1991 Oct; 57(2):153-65. PubMed ID: 1812297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity and dissimilarity in mode and mechanism of action between YT-146, a selective adenosine receptor A2 agonist, and adenosine in isolated canine hearts.
    Yoneyama F; Aihara K; Kogi K; Satoh K; Taira N
    Tohoku J Exp Med; 1999 May; 188(1):31-45. PubMed ID: 10494898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
    Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
    Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antihypertensive effect of 2-alkynyladenosines and their selective affinity for adenosine A2 receptors.
    Abiru T; Yamaguchi T; Watanabe Y; Kogi K; Aihara K; Matsuda A
    Eur J Pharmacol; 1991 Apr; 196(1):69-76. PubMed ID: 1874281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein.
    Abiru T; Endo K; Machida H
    Eur J Pharmacol; 1995 Jul; 281(1):9-15. PubMed ID: 8566123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of 2-octynyladenosine (YT-146), a selective adenosine A2 receptor agonist, in Dahl salt-sensitive rats.
    Iwamoto T; Umemura S; Toya Y; Hirawa N; Takeda K; Kihara M; Ishii M
    Am J Hypertens; 1994 Nov; 7(11):984-8. PubMed ID: 7848625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury.
    Takiguchi Y; Nagano M; Ikeda Y; Nakashima M
    Eur J Pharmacol; 1995 Aug; 281(2):205-7. PubMed ID: 7589208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts.
    Sasamori J; Abe Y; Marunouchi T; Manome Y; Uchibori T; Tanonaka K
    Biol Pharm Bull; 2015; 38(12):1946-53. PubMed ID: 26632185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
    Ghai G; Francis JE; Williams M; Dotson RA; Hopkins MF; Cote DT; Goodman FR; Zimmerman MB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):784-90. PubMed ID: 3656113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    Martin PL; Ueeda M; Olsson RA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YT-146 [2-(1-octynyl) adenosine], an adenosine A2A receptor agonist, on cAMP production and noradrenaline release in PC12 cells.
    Ono T; Matsuoka I; Ohkubo S; Kimura J; Nakanishi H
    Jpn J Pharmacol; 1998 Nov; 78(3):269-77. PubMed ID: 9869260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications.
    Froldi G; Belardinelli L
    Circ Res; 1990 Oct; 67(4):960-78. PubMed ID: 2208618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists.
    Kanda A; Haruno A; Miyoshi K; Tanahashi Y; Miyake H; Ichihara K; Okumura K; Nagasaka M
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):167-75. PubMed ID: 7690090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular actions of 1-methylisoguanosine.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1981; 8(6):575-84. PubMed ID: 7333043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.